GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beryl Drugs Ltd (BOM:524606) » Definitions » Cash And Cash Equivalents

Beryl Drugs (BOM:524606) Cash And Cash Equivalents : ₹0.0 Mil (As of Dec. 2024)


View and export this data going back to 1994. Start your Free Trial

What is Beryl Drugs Cash And Cash Equivalents?

Beryl Drugs's quarterly cash and cash equivalents increased from Jun. 2024 (₹0.00 Mil) to Sep. 2024 (₹0.79 Mil) but then stayed the same from Sep. 2024 (₹0.79 Mil) to Dec. 2024 (₹0.00 Mil).

Beryl Drugs's annual cash and cash equivalents increased from Mar. 2022 (₹2.71 Mil) to Mar. 2023 (₹2.83 Mil) but then declined from Mar. 2023 (₹2.83 Mil) to Mar. 2024 (₹1.25 Mil).


Beryl Drugs Cash And Cash Equivalents Historical Data

The historical data trend for Beryl Drugs's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beryl Drugs Cash And Cash Equivalents Chart

Beryl Drugs Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cash And Cash Equivalents
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.96 4.52 2.71 2.83 1.25

Beryl Drugs Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cash And Cash Equivalents Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1.25 - 0.79 -

Beryl Drugs Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.


Beryl Drugs  (BOM:524606) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.


Beryl Drugs Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Beryl Drugs's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.


Beryl Drugs Business Description

Traded in Other Exchanges
N/A
Address
133, Kanchan Bagh, Ground Floor, Indore, MP, IND, 452001
Beryl Drugs Ltd is a pharmaceutical company principally engaged in the manufacturing and marketing of allopathic pharmaceutical preparations. It also provides contract manufacturing services and veterinary products. It offers manufacturing options for product requirements like small-volume injectables in liquid form, small-volume injectables in dry powder form, eye and ear drops, intravenous fluids in poly pack and glass bottles, and veterinary medicines. The company earns the majority of its revenue from the sale of Bulk Drugs.

Beryl Drugs Headlines

No Headlines